Skip to main content
. 2021 Oct 27;11:763468. doi: 10.3389/fonc.2021.763468

Table 1.

Patient characteristics.

Immune checkpoint inhibitor-induced colitis (irAE) n = 18 Ulcerative colitis (UC)n = 9 P value
Age, years Median (range) 66.5 (43 to 79) 23.0 (14 to 49) <0.001
Gender Male 13 (72.2%) 3 (33.3%) 1.000
Female 5 (27.8%) 6 (66.6%)
Geboes score grade Grade 1 3 (16.7%) 1 (11.1%) 0.426
Grade 2 9 (50.0%) 2 (22.2%)
Grade 3 1 (5.6%) 1 (11.1%)
Grade 4 5 (27.8%) 5 (55.6%)
Colitis activity Mild 9 (50.0%) 1 (11.1%) 0.059
Moderate 7 (38.9%) 4 (44.4%)
Severe 2 (11.1%) 4 (44.4%)
Cancer types Lung 11 (61.1%)
Stomach 2 (11.1%)
Kidney 3 (16.7%)
Ovary 1 (5.6%)
Unknown 1 (5.6%)
Availability of inactive tissue Yes 14 (77.8%) 9 (100%)
No 4 (22.2%) 0 (0%)
Availability of active tissue Yes 15 (83.3%) 9 (100%)
No 3 (16.7%) 0 (0%)

*P values were based on the Fisher’s exact test for categorical data and the Mann-Whitney U test for continuous data.